For over 40 years Ofichem has been working to improve health for humans and animals by providing high quality Active Pharmaceutical Ingredients. API’s that not only meet our client’s needs but also comply with stringent health and safety regulations.
It is with pleasure that we present an overview of who we at Ofichem are, how we work and, most importantly, how we can be of service to you.
Our mission is to help improve health in humans and animals and to do so we work in close collaboration with our clients, developing, manufacturing and sourcing API’s and distributing them across the globe. Throughout the whole of the process, our emphasis is on having quality products and collaborating with our clients and partners. Our teams work closely with our clients so that they can respond to market demands, meet country-specific regulations and develop their products for their specific purposes. We take our clients through the complete process of bringing an API to market, from development and production to regulation and distribution, so that in the end, together, we can make a difference to the health of humans and animals.
All-round in API’s
To be a leading company in the field of API’s offering a diversity of synergetic complementary
activities and with both forward and backward integration.
We believe that the health of humans and animals can be improved by being client-focused
in the pharmaceutical market.
Flexibility has been part of Ofichem’s character since its founding. With its roots in chemical synthesis, Ofichem has, over the years, adapted and pre-empted market developments so that it now provides an all-round service to its clients. Ofichem not only develops and produces active pharmaceutical ingredients for large and small companies alike, but also analyses, sources and distributes API’s, checks regulatory requirements and ensures supplier qualifications are in place.
When manufacturing regulations were tightened in the late 1990s, it was flexibility and a good understanding of the market that helped Ofichem move on. “Stringent GMP requirements were badly affecting European and American API producers while, in contrast, the Asian market was strengthening. Our answer was to create trading companies, Incopharm and Ofichem, that could source quality raw materials in Asia and export them to Europe and beyond. And we made the necessary investments in our own production facility so that production would be fully in accordance with GMP legislation.”
The result was a state-of-the-art production facility that could answer to the different needs of Ofichem’s clients. More recently, Ofichem has reorganised its structure, establishing business units to cover its range of expertise, from quality assurance to regulatory affairs, from research to development, so as to provide its clients with a full range of services for taking API’s to market. The company’s in-house expertise in pharmaceutics and GMP regulations means there’s a healthy balance between developing creative innovations and ensuring these innovations meet regulations. Teams are put together specially for each project so Ofichem’s clients receive a professional and personal service with the right combination of expertise and experience.
Intimate knowledge of the market remains essential to helping Ofichem achieve its mission of making medicines more available for everybody. “Our expertise and strong background in the lab has meant we’ve been able to launch highly successful API sourcing companies.”
The quality Ofichem places on its products is the same whether the API is produced by Ofichem itself or sourced from external parties. “And, in turn, the trading companies work like antennas picking up the signals in the market to keep our research and production businesses up to date with the latest demands and developments. Although each Ofichem business unit operates independently, there’s a definite synergy within the group; sharing expertise and values, drawing on each other’s resources and making the highest quality medication available across the market.”
“OFICHEM ANSWERS AND ANTICIPATES ITS CLIENTS’ NEEDS IN THE INTERNATIONAL MARKET”